Goldman Sachs Group Inc Foghorn Therapeutics Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 45,557 shares of FHTX stock, worth $365,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,557
Previous 15,194 199.84%
Holding current value
$365,822
Previous $87,000 387.36%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$4.8 - $9.99 $145,742 - $303,326
30,363 Added 199.84%
45,557 $424,000
Q2 2024

Aug 13, 2024
BUY
$5.05 - $8.0 $19,053 - $30,184
3,773 Added 33.04%
15,194 $87,000
Q1 2024

May 15, 2024
SELL
$2.82 - $7.94 $7,952 - $22,390
-2,820 Reduced 19.8%
11,421 $76,000
Q4 2023

Feb 13, 2024
SELL
$2.94 - $6.76 $5,027 - $11,559
-1,710 Reduced 10.72%
14,241 $91,000
Q3 2023

May 14, 2024
BUY
$5.0 - $9.87 $8,550 - $16,877
1,710 Added 12.01%
15,951 $79,000
Q3 2023

Nov 14, 2023
BUY
$5.0 - $9.87 $3,670 - $7,244
734 Added 4.82%
15,951 $79,000
Q2 2023

May 14, 2024
SELL
$5.37 - $8.84 $85,157 - $140,184
-15,858 Reduced 51.03%
15,217 $107,000
Q2 2023

Aug 14, 2023
SELL
$5.37 - $8.84 $85,157 - $140,184
-15,858 Reduced 51.03%
15,217 $107,000
Q1 2023

May 14, 2024
SELL
$4.66 - $8.99 $13,085 - $25,243
-2,808 Reduced 8.29%
31,075 $192,000
Q1 2023

May 11, 2023
SELL
$4.66 - $8.99 $13,085 - $25,243
-2,808 Reduced 8.29%
31,075 $192,000
Q4 2022

May 14, 2024
BUY
$5.44 - $9.46 $92,267 - $160,451
16,961 Added 100.23%
33,883 $216,000
Q4 2022

Feb 13, 2023
BUY
$5.44 - $9.46 $92,267 - $160,451
16,961 Added 100.23%
33,883 $216,000
Q3 2022

May 14, 2024
BUY
$7.52 - $18.01 $4,090 - $9,797
544 Added 3.32%
16,922 $145,000
Q3 2022

Nov 10, 2022
BUY
$7.52 - $18.01 $4,090 - $9,797
544 Added 3.32%
16,922 $145,000
Q2 2022

May 14, 2024
BUY
$8.48 - $16.84 $18,121 - $35,987
2,137 Added 15.01%
16,378 $223,000
Q2 2022

Aug 15, 2022
BUY
$8.48 - $16.84 $27,415 - $54,443
3,233 Added 24.59%
16,378 $223,000
Q1 2022

May 16, 2022
SELL
$8.87 - $22.1 $206,653 - $514,885
-23,298 Reduced 63.93%
13,145 $200,000
Q4 2021

Feb 14, 2022
BUY
$10.79 - $22.87 $255,010 - $540,509
23,634 Added 184.51%
36,443 $833,000
Q3 2021

Nov 10, 2021
BUY
$8.33 - $15.02 $106,698 - $192,391
12,809 New
12,809 $178,000

Others Institutions Holding FHTX

# of Institutions
80
Shares Held
33.3M
Call Options Held
8.7K
Put Options Held
2.4K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $334M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email